Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

In the past decade, molecular-targeted drugs have been focused upon for the treatment of cancer. In 2002, gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor became available in Japan for the treatment of non-small cell lung cancer (NSCLC). Over 80% of selected patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Takuya, Yashima, Hideaki, Shimizu, Kimihiro, Aomori, Tohru, Hashita, Tadahiro, Kaira, Kyoichi, Nakamura, Tomonori, Yamamoto, Koujirou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520446/
https://www.ncbi.nlm.nih.gov/pubmed/23239933
http://dx.doi.org/10.4137/CMO.S7340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520446/
https://www.ncbi.nlm.nih.gov/pubmed/23239933
http://dx.doi.org/10.4137/CMO.S7340

Ejemplares similares